CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Promoting patient-centered care in CAR-T therapy for hematologic malignancy: a qualitative meta-synthesis.
Promoting patient-centered care in CAR-T therapy for hematologic malignancy: a qualitative meta-synthesis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
为确保 CAR-T 疗法的安全性和可持续性,解决患者体验中的身体和心理方面至关重要。有效的沟通和综合管理受到患者及其照护者的高度重视。进一步的研究应探讨减轻负担的方法,并为患者及其家庭制定自我管理教育计划。
CAR-T 疗法已成为血液系统恶性肿瘤患者的一种潜在有效治疗方法。了解患者对这种治疗方法的独特体验至关重要。这些知识将有助于制定量身定制的护理干预措施,以契合日益重要的以患者为中心的护理。
目的:检查并综合关于患者及其家庭照护者在治疗旅程中体验的定性数据。
我们进行了一项系统综述和定性元综合。符合条件的研究包含成年患者或家庭照护者关于CAR-T 治疗体验的引述,且为2015年以来发表在同行评审期刊上的英文或中文文献。数据来源包括MEDLINE、CINAHL、Embase、PsycINFO、Web of Science、Scopus、Cochrane Library、CNKI和WanFang。系统检索共识别出6373篇文章。其中,12篇报告被纳入分析,涵盖11项独立研究。两名评审员独立将数据提取至NVIVO 12.0。定性元综合通过对全文进行逐行编码、将编码组织为描述性主题以及形成发展性主题来完成。
定性meta整合得出八个主要主题。患者及其家庭照护者对CAR-T 治疗历程的重要揭示涵盖多个方面。在CAR-T 治疗前,患者缺乏实际选择,挣扎于对治疗结果的期望,并经历复杂的情绪体验。在CAR-T 治疗期间或紧随其后,患者报告了舒适和不舒适的体验。此外,患者强调,对治疗疗效和不良反应的担忧加剧了治疗相关痛苦。在CAR-T 治疗后,观察到显著变化,以及居家康复负担。此外,我们发现导致CAR-T 治疗费用高昂的因素。
CAR-T therapy has emerged as a potentially effective treatment for individuals diagnosed with hematologic malignancies. Understanding patients' unique experiences with this therapeutic approach is essential. This knowledge will enable the development of tailored nursing interventions that align with the increasing importance of patient-centered care.
To examine and synthesize qualitative data on patients and their family caregivers' experiences during the treatment journey. DESIGN: We conducted a systematic review and qualitative meta-synthesis. Eligible studies contained adult patient or family caregiver quotes about experiences of CAR-T therapy, published in English or Chinese in a peer-reviewed journal since 2015. Data sources included MEDLINE, CINAHL, Embase, PsycINFO, Web of Science, Scopus, Cochrane Library, CNKI, and WanFang.
Systematic search yielded 6373 identified articles. Of these, 12 reports were included in the analysis, which covered 11 separate studies. Two reviewers independently extracted data into NVIVO 12.0. Qualitative meta-synthesis was performed through line-by-line coding of full text, organization of codes into descriptive themes, and development themes.
The qualitative meta-synthesis yielded eight primary themes. Noteworthy revelations from patients and their family caregivers regarding the CAR-T therapy journey encompassed various aspects. Prior to CAR-T therapy, patients experienced a lack of actual choice, struggled with expectations for treatment outcomes, and encountered intricate emotional experiences. During or immediately after CAR-T therapy, patients reported both comfortable and uncomfortable experiences. Additionally, patients emphasized that concerns regarding treatment efficacy and adverse reactions intensified treatment-related distress. After CAR-T therapy, significant changes were observed, and the burden of home-based rehabilitation. Additionally, we found factors contributed to the high CAR-T therapy cost.
To ensure the safety and sustainability of CAR-T therapy, it is crucial to address the physical and psychological aspects of the patient's experience. Effective communication and comprehensive management are highly valued by patients and their caregivers. Further research should investigate ways to reduce burdens and develop self-management education programs for patients and their families.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。